Showing results (441-450 of 460) with videos related to

Sort By:
Pageof 46
European Journal of Immunology|November 11, 1999
Comparison of IgE and IgG antibody-dependent cytotoxicity in vitro and in a SCID mouse xenograft model of ovarian carcinomaH J Gould, G A Mackay, S N Karagiannis, et al.
Plos One|June 19, 2018
Structural definition of hSP-D recognition of Salmonella enterica LPS inner core oligosaccharides reveals alternative binding modes for the same LPSJamie R Littlejohn, Ruben F da Silva, William A Neale, et al.
Nature Communications|June 4, 2025
Perinatal serotonin signalling dynamically influences the development of cortical GABAergic circuits with consequences for lifelong sensory encodingGabriel Ocana-Santero, Hannah Warming, Veronica Munday, et al.
Translational Psychiatry|July 27, 2012
Olfactory discrimination predicts cognitive decline among community-dwelling older adultsH R Sohrabi, K A Bates, M G Weinborn, et al.
The Journal of Pathology|May 20, 2008
Genomic and immunophenotypical characterization of pure micropapillary carcinomas of the breastC Marchiò, M Iravani, R Natrajan, et al.
British Journal of Cancer|August 27, 2009
Expression, mutation and copy number analysis of platelet-derived growth factor receptor A (PDGFRA) and its ligand PDGFA in gliomasO Martinho, A Longatto-Filho, M B K Lambros, et al.
The Journal of Clinical Investigation|April 4, 2007
Involvement of PLEKHM1 in osteoclastic vesicular transport and osteopetrosis in incisors absent rats and humansLiesbeth Van Wesenbeeck, Paul R Odgren, Fraser P Coxon, et al.
The Journal of Pathology|July 11, 2006
Array CGH profiling of favourable histology Wilms tumours reveals novel gains and losses associated with relapseR Natrajan, R D Williams, S N Hing, et al.
Oncogene|January 22, 2013
Integrative molecular and functional profiling of ERBB2-amplified breast cancers identifies new genetic dependenciesK-K Shiu, D Wetterskog, A Mackay, et al.
The Journal of Infectious Diseases|April 16, 2025
Impact of pharmacogenetics on pharmacokinetics of first-line anti-tuberculosis drugs in the HIRIF trialE A Mackay, G Platt, C A Peloquin, et al.
Pageof 46